Asbestosis Clinical Trials Asbestosis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural Mesothelioma
Condition:   Pleural Mesothelioma Intervention:   Drug: Cadonilimab+Bevacizumab+Pemetrexed+Carboplatin Sponsor:   Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 5, 2023 Category: Research Source Type: clinical trials